Functional Activity of TDP 43: A Direct Biomarker for ALS
Preprint
Abstract
TDP-43 dysfunction is a defining feature of amyotrophic lateral sclerosis (ALS), yet no biofluid biomarker directly measures its functional activity. We developed a serum-based homogeneous time-resolved FRET (hTR-FRET) assay that quantifies TDP-43 RNA binding activity using synthetic UU-rich RNA probes. We analyzed 1,080 serum samples from controls, sporadic ALS, and genetic subgroups (C9orf72, SOD1) across multiple biorepositories. Cross-sectionally, TDP-43 functional activity was elevated in ALS (mean 390 a.u.) versus controls (304 a.u.), yielding AUC = 0.79. Genotype means were 392 a.u. (sporadic), 382 a.u. (C9orf72), and 323 a.u. (SOD1); a 366 a.u. threshold achieved 95% specificity against controls. Longitudinally, Target ALS showed a modest but significant inverse correlation between TDP-43 activity and ALSFRS-R, while other cohorts exhibited similar non-significant trends. Elevated signal in serum likely reflects increased extracellular, probe-competent TDP-43 species. This assay provides a proof-of-concept platform for the direct functional measurement of probe-competent TDP-43 species in serum. While it demonstrates moderate group-level discrimination, individual diagnostic performance requires prospective validation. The assay may support exploratory applications in genotype stratification and progression monitoring in future clinical studies.Keywords
This publication has 22 references indexed in Scilit:
- Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathyCell Reports, 2025
- Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosisAging and Health Research, 2024
- Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocolsScientific Reports, 2024
- Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTDNeurotherapeutics, 2022
- The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studiesExperimental & Molecular Medicine, 2020
- Splicing repression is a major function of TDP-43 in motor neuronsActa Neuropathologica, 2019
- Addition of exogenous SOD1 aggregates causes TDP-43 mislocalisation and aggregationCell Stress and Chaperones, 2017
- TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashionScientific Reports, 2016
- Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43Nature Structural & Molecular Biology, 2013
- Characterization and Functional Implications of the RNA Binding Properties of Nuclear Factor TDP-43, a Novel Splicing Regulator ofCFTR Exon 9Journal of Biological Chemistry, 2001